Doctors typically recommend that people with heart issues like A-Fib avoid caffeine out of fear that it will trigger symptoms. But a study by UC San Francisco and the University of Adelaide concluded ...
A new study finds that risk-based breast cancer screening could be as safe as annual mammograms, but an expert warns it may ...
A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a ...
A phase 1 randomized clinical trial of a novel Nipah virus vaccine is leading to hope that there could soon be a way to prevent infection. The study found that the shots were safe and generated an ...
Indivior (INDV) announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the ...
TipRanks on MSN
Neurocrine Biosciences advances schizophrenia treatment with new Phase 2a clinical study
Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has announced the initiation of a Phase ...
Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the first patient has been randomized in the RASolute ...
Vixarelimab showed significant symptom relief and disease progression reduction in prurigo nodularis compared with placebo across all doses. A phase 2b trial found vixarelimab rapidly reduced itch and ...
Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback